Prednisone Active Not Recruiting Phase 1 / 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01792687Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate